122 related articles for article (PubMed ID: 17984022)
1. [Malignant tumors following renal transplantation].
Végso G; Járay J
Orv Hetil; 2007 Nov; 148(45):2115-23. PubMed ID: 17984022
[TBL] [Abstract][Full Text] [Related]
2. [Cancer after kidney transplantation].
Sandrini S; Setti G; Bossini N; Maiorca P
G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996.
Lesnoni La Parola I; Masini C; Nanni G; Diociaiuti A; Panocchia N; Cerimele D
Dermatology; 1997; 194(3):229-33. PubMed ID: 9187838
[TBL] [Abstract][Full Text] [Related]
4. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
Végso G
Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
[TBL] [Abstract][Full Text] [Related]
5. Malignancy after transplantation.
Buell JF; Gross TG; Woodle ES
Transplantation; 2005 Oct; 80(2 Suppl):S254-64. PubMed ID: 16251858
[TBL] [Abstract][Full Text] [Related]
6. The role of mTOR inhibitors in the management of posttransplant malignancy.
Monaco AP
Transplantation; 2009 Jan; 87(2):157-63. PubMed ID: 19155967
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Kaposi's sarcoma in a renal transplant recipient maintained on minimum doses of immunosuppression.
Sabeel A; Qunibi W
Nephrol Dial Transplant; 1998 Jun; 13(6):1609-10. PubMed ID: 9641212
[No Abstract] [Full Text] [Related]
8. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
9. Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation.
Fraile P; García-Cosmes P; Martín P; García-Bernalt V; Tabernero JM
Transplant Proc; 2009; 41(6):2433-4. PubMed ID: 19715943
[TBL] [Abstract][Full Text] [Related]
10. Oral Kaposi's sarcoma in a renal transplant patient: case report and literature review.
Darling M; Thompson I; Meer M
J Can Dent Assoc; 2004 Oct; 70(9):617-20. PubMed ID: 15473946
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
12. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
[TBL] [Abstract][Full Text] [Related]
13. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
14. [Kaposi's angiosarcoma in a renal transplant patient].
Martí R; Bou D; Torras H
Actas Dermosifiliogr; 1981; 72(5-6):215-8. PubMed ID: 7032247
[No Abstract] [Full Text] [Related]
15. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
Pomerantz RG; Campbell LS; Jukic DM; Geskin LJ
Arch Dermatol; 2010 May; 146(5):513-6. PubMed ID: 20479299
[TBL] [Abstract][Full Text] [Related]
17. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
[TBL] [Abstract][Full Text] [Related]
18. For organ transplant recipients, cancer threatens long-term survival.
Ross K
J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
[No Abstract] [Full Text] [Related]
19. [Kaposi's sarcoma in 2 patients after renal transplantation].
Gómez Uribe JI; Arango Acosta JL
Med Cutan Ibero Lat Am; 1984; 12(3):215-9. PubMed ID: 6384692
[TBL] [Abstract][Full Text] [Related]
20. Malignancy after solid organ transplantation: an overview.
Zafar SY; Howell DN; Gockerman JP
Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
